APLMW — Apollomics Inc.

Nasdaq · Health Care · Pharmaceuticals · CIK 1944885 ·
Last close
$0.01
Market Cap
52W High
$0.01
52W Low
$0.01
ADV30
0
Next earnings
Euronext Athens Holding S.A. provides support services for the operation of the Greek capital market. The company operates through Trading, Post trading, Listing, Data Services, IT and digital services, and Ancillary services segments. It provides clearing, settlement, and registry services; cross-border trades; initial public offers (IPOs) and corporate actions related services; data services, including information on the cash, bond, and derivatives market; and support services for other markets, such as the energy exchange group, education, rents, and event organization services. In addition, the company operates the infrastructure for various markets, including stocks, bonds, exchange-traded funds, and derivatives; and multilateral trading facility (MTF) for smaller companies. Further, it offers a clearing platform; information technology systems and infrastructure for trading, clearing, settlement, and registry; and technological and consulting solutions. Additionally, the company engages in activities relating to the provision of central securities depository services, as well as operate as a system administrator in the Athens Exchange Clearing House. The company was formerly known as Hellenic Exchanges - Athens Stock Exchange S.A. and changed its name to Euronext Athens Holding S.A. in April 2026. The company was founded in 1876 and is headquartered in Athens, Greece. Euronext Athens Holding S.A. operates as a subsidiary of Euronext N.V.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 6,714,000 3,276,000 9,902,000
Jun 2025 11,119,000 2,094,000 15,517,000
Dec 2024 13,098,000 9,766,000 8,234,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-711,762,000
Inventory
Receivables
$2,490,000
ST Investments
$0
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 8,500,000 -9,194,000 -10,939,000 6,714,000 9,902,000 -10,369,000
Dec 2024 0 -42,033,000 -53,858,000 13,098,000 8,234,000 -28,743,000
Dec 2023 0 -54,370,000 -172,601,000 55,387,000 14,153,000 -43,209,000
Dec 2022 0 -44,388,000 -240,811,000 76,475,000 524,595,000 -42,824,000
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.01T $1133.00
JNJ JOHNSON & JOHNSON $579.83B $240.87
ABBV AbbVie Inc. $402.35B $227.73
MRK Merck & Co., Inc. $294.03B $119.05
NVS NOVARTIS AG $292.07B $153.07

News headlines (Yahoo Finance, 1h cache)

Apollomics Inc. Announces $2.0 Million Bridge Financing
2026-04-01 11:00 · Yahoo
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation
2025-10-15 18:36 · Yahoo
Apollomics, Inc. Company Operational Continuity Update
2025-10-14 01:22 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.